|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|
| Revenue | |
| Cost of revenue | |
| Gross profit | |
| Operating expenses: | |
| Research and development | |
| Sales and marketing | |
| General and administrative | |
| Change in fair value of contingent consideration | |
| Total operating expenses | |
| Loss from operations | |
| Other income, net | |
| Loss before provision for income taxes | |
| Provision for (benefit from) income taxes | |
| Net loss | |
| Accretion of redeemable convertible preferred stock | |
| Net loss attributable to common stockholders | |
| Net loss per share attributable to common stockholders, basic and diluted (in dollars per share) | |
| Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted (in shares) |
Loading...
